syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.5181308	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.80571555494427
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.99757016984306
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.3	85.63162014761838
SECKEL SYNDROME 10; SCKL10	1.25	82.3380962957869
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	1.1	72.45752474029248
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	1.0909091	71.85870282060017
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	1.051479871	69.26148069718366
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0412005	68.58437362577718
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.02309351	67.39165755677969
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0217391	67.3024419239765
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.020573861	67.22568707518482
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0188679	67.11331461030893
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	1.0147059	66.83916168488248
HYDROXYKYNURENINURIA	1.0140845	66.79822977045194
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	1.009924761	66.52422577817406
SENGERS SYNDROME	1.00900901	66.46390482295729
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.87047703662951
SPLENOPORTAL VASCULAR ANOMALIES	1.0	65.87047703662951
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	1.0	65.87047703662951
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	1.0	65.87047703662951
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	1.0	65.87047703662951
BARTH SYNDROME; BTHS	1.0	65.87047703662951
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.0	65.87047703662951
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0	65.87047703662951
CHIARI MALFORMATION TYPE II	1.0	65.87047703662951
CLUSTER HEADACHE, FAMILIAL	1.0	65.87047703662951
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	1.0	65.87047703662951
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	65.87047703662951
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.958333	63.12585186994427
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	62.47239038955009
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.8432577609999999	55.545790981910116
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.7801568509999999	51.389303938764684
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.7647059	50.37154242572511
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.7222219	47.57310107930094
GLUTARIC ACIDEMIA I; GA1	0.6927783510000001	45.63364046101957
Congenital disorder of glycosylation, type IIh	0.6150214	40.51175300573574
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.5909091	38.92346430228542
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5826286	38.37802381718361
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.5517354000000001	36.3430739959956
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.5369281	35.367710081371115
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.53568941	35.28611698017062
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.53374261	35.1578803354757
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.5297616	34.89564930768812
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.903923166567736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.50900901	33.52866630464252
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.508728251	33.510172575380196
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.5078125	33.44985162016343
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.500915751	32.99555947353153
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.500915751	32.99555947353153
GLUTATHIONE SYNTHETASE DEFICIENCY	0.500915751	32.99555947353153
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.935238518314755
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	32.935238518314755
RENAL TUBULAR ACIDOSIS III	0.5	32.935238518314755
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.5	32.935238518314755
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5	32.935238518314755
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.935238518314755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.5	32.935238518314755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.935238518314755
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.5	32.935238518314755
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.5	32.935238518314755
COMBINED SAPOSIN DEFICIENCY	0.5	32.935238518314755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.4987168	32.85071352218136
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.485743351	31.99614624774097
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.71994191804817
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	29.53715187123534
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	29.53715187123534
CENTRALOPATHIC EPILEPSY	0.44841259999999994	29.537151871235334
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.41473679999999996	27.318910860645207
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.40694149999999996	26.805430731001568
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.19405442534991
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.7194642253487
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.7194642253487
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.375	24.701428888736068
PROPIONIC ACIDEMIA	0.36799136099999996	24.23976649442854
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.36307049999999996	23.915627032927596
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.3619044	23.838815469655184
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.3617249	23.82699171902711
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.802402269949336
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.69023802165136
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.356767151	23.500422427369237
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.34945611	23.01884066906488
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.348958	22.986029925748163
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.348958	22.986029925748163
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.925488370303796
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.345359851	22.749018134669292
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.34279576100000003	22.580120303204442
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.342061251	22.531737779116266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.3407755	22.447044747395942
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.334248751	22.0171246772676
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.334248751	22.0171246772676
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.334248751	22.0171246772676
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.334248751	22.0171246772676
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.334248751	22.0171246772676
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.333333	21.95680372205083
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.333333	21.95680372205083
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	21.95680372205083
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	21.95680372205083
PARAGANGLIOMAS 3	0.333333	21.95680372205083
PARAGANGLIOMAS 4	0.333333	21.95680372205083
PARAGANGLIOMAS 1	0.333333	21.95680372205083
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.3272339	21.555053095556723
TUBEROUS SCLEROSIS	0.32591575100000003	21.468225992121365
AICARDI SYNDROME; AIC	0.325	21.407905036904594
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.28818902	18.983148224118764
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.2764946	18.21283120005206
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.270573861	17.82282929771269
INFANTILE LIVER FAILURE SYNDROME 2	0.269839351	17.774446773624515
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.43630390741035
ARGININOSUCCINIC ACIDURIA	0.250915751	16.52794021437415
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.250915751	16.52794021437415
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.250915751	16.52794021437415
ALPHA-METHYLACETOACETIC ACIDURIA	0.25	16.467619259157377
HYPEREKPLEXIA 1; HKPX1	0.25	16.467619259157377
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	16.467619259157377
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	16.467619259157377
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.25	16.467619259157377
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.25	16.467619259157377
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.467619259157377
PATENT DUCTUS VENOSUS	0.25	16.467619259157377
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.25	16.467619259157377
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	16.467619259157377
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.25	16.467619259157377
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.25	16.467619259157377
GLYCOGEN STORAGE DISEASE 0, LIVER	0.23214676099999995	15.291617889578418
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.2267024	14.9329952333488
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.783186007424392
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.21635951	14.251704135111416
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.21202675099999999	13.966303232896662
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.21111110000000002	13.9059888647276
TIGLIC ACIDEMIA	0.211111	13.905982277679893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.21086960000000002	13.890081144523252
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.21086960000000002	13.890081144523252
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.208728251	13.749029464391343
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.200915751	13.234416362542675
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.2	13.174095407325904
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.2	13.174095407325904
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.2	13.174095407325904
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.2	13.174095407325904
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.19841110000000003	13.069433806362404
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	12.808138798053504
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	12.808138798053504
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	12.808138798053504
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	12.808138798053504
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	12.808138798053504
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	12.808138798053504
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	12.808138798053504
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.1935702	12.750561414075785
PEHO-LIKE SYNDROME; PEHOL	0.1855349	12.221272369943355
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.942284551502414
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.1812995	11.942284551502414
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.171664381	11.307614666667721
PEHO SYNDROME; PEHO	0.167582751	11.038755751480704
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.167582751	11.038755751480704
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.167582751	11.038755751480704
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.167582751	11.038755751480704
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.167582751	11.038755751480704
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.16747086099999997	11.031385503805073
#607398 GLUCOCORTICOID DEFICIENCY 2; GCCD2;;FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2	0.166667	10.978434796263931
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.166667	10.978434796263931
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.15694149999999998	10.33781147184419
GALACTOSEMIA	0.15694149999999998	10.33781147184419
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.15694149999999998	10.33781147184419
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.1564005	10.302175543767374
PYRUVATE CARBOXYLASE DEFICIENCY	0.154582871	10.182447454461764
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.151928251	10.007586368710784
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.145769361	9.601897346394656
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1433483	9.442420903389879
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.14285699999999998	9.410058738021782
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14285699999999998	9.410058738021782
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.14285699999999998	9.410058738021782
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.14285699999999998	9.410058738021782
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.140000251	9.221883318617868
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.1358696	8.949795366776039
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.854605940410405
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.13366071999999998	8.804295387459367
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13339445100000002	8.786756121409303
MAPLE SYRUP URINE DISEASE; MSUD	0.131684861	8.674144612572249
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.13121305100000002	8.643066262801598
GLYCOGEN STORAGE DISEASE IXA	0.1300346	8.565441133267305
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	8.562989499982478
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.12908163	8.502668544765708
GLYCOGEN STORAGE DISEASE IXC	0.12747050999999998	8.396543301802453
METHYLMALONIC ACIDURIA, CBLA TYPE	0.12611125099999998	8.30700826305612
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.294130584795461
LOWE OCULOCEREBRORENAL SYNDROME	0.125915751	8.294130584795461
CHROMOSOME 1P36 DELETION SYNDROME	0.125915751	8.294130584795461
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.282810677446237
METHYLMALONIC ACIDURIA, CBLB TYPE	0.1251955	8.24668730783935
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125	8.233809629578689
SAY SYNDROME	0.125	8.233809629578689
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.124303461	8.187928273374073
HYPOTONIA-CYSTINURIA SYNDROME	0.11965800999999998	7.881930199953784
GLYCEROL KINASE DEFICIENCY; GKD	0.11702045100000001	7.708192930411531
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.11702045100000001	7.708192930411531
#300867 KABUKI SYNDROME 2; KABUK2	0.112026751	7.3792555292337125
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.112026751	7.3792555292337125
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.112026751	7.3792555292337125
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.112026751	7.3792555292337125
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.1111111	7.318941161064646
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	7.318934574016941
BECKWITH-WIEDEMANN SYNDROME	0.11111099999999999	7.318934574016941
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.11053337100000002	7.280885876236752
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.12117164080987
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.1078125	7.10166080551162
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.1078125	7.10166080551162
ALAGILLE SYNDROME 1; ALGS1	0.1078125	7.10166080551162
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.1065341	7.017451987667993
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.10590935100000001	6.976299473009837
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.10116610000000001	6.663859266935367
VICI SYNDROME; VICIS	0.10091575100000001	6.647368658879723
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.587047703662952
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.1	6.587047703662952
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.587047703662952
WHITE-SUTTON SYNDROME; WHSUS	0.1	6.587047703662952
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.587047703662952
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.1	6.587047703662952
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.587047703662952
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.587047703662952
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.09895495100000001	6.5182098275063
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.09579100000000002	6.309798865815779
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	6.257084699157675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.09340280000000001	6.1524869925569
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.09332560000000001	6.147401791729672
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.09332560000000001	6.147401791729672
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.092741	6.108893910854058
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.09182485100000001	6.048546739187428
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	6.048546739187428
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.0909091	5.988225783970657
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	5.988225783970657
ATRANSFERRINEMIA	0.0909091	5.988225783970657
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0909091	5.988225783970657
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0909091	5.988225783970657
RCAD (renal cysts and diabetes)	0.0909091	5.988225783970657
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	5.988225783970657
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0909091	5.988225783970657
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	5.988225783970657
SITOSTEROLEMIA	0.0909091	5.988225783970657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.08990037100000002	5.921780323539975
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.910660069606651
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.85033911438988
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08424905100000002	5.54952517925333
KEARNS-SAYRE SYNDROME; KSS	0.08089136100000001	5.328352537212209
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.07959623	5.243041640417282
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	5.19513206635423
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.146131018486681
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.07777780000000001	5.1232607888595645
LISSENCEPHALY 2; LIS2	0.07692310000000001	5.066961292136356
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.07692310000000001	5.066961292136356
MYOCLONUS AND ATAXIA	0.07692310000000001	5.066961292136356
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.07692310000000001	5.066961292136356
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.066961292136356
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.066961292136356
CANAVAN DISEASE	0.07692310000000001	5.066961292136356
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.066961292136356
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.902311447735597
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.902311447735597
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.07402737100000001	4.876218241537555
Polyarteritis nodosa, childhood-onset	0.0728289	4.7972743850529875
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.07234435100000002	4.765356911275367
ALAGILLE SYNDROME 2	0.07142860000000001	4.705035956058596
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.07142860000000001	4.705035956058596
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.07142860000000001	4.705035956058596
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.07142860000000001	4.705035956058596
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.628158522309145
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.628158522309145
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.069557751	4.581802239965094
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.06886251	4.536006383639671
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.06833151	4.50102916033322
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.065779561	4.33293106233007
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.22644741810126
CHROMOSOME 17q12 DELETION SYNDROME	0.06336810000000001	4.174086975904843
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	4.165905862656893
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	4.165905862656893
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0625	4.116904814789344
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.061745250999999994	4.067189138116426
MENTAL RETARDATION, X-LINKED 98; MRX98	0.061724451	4.065819032194064
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.9449565215329274
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.7313451515508413
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.659473874056175
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.055555600000000004	3.659473874056175
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.659473874056175
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.055555600000000004	3.659473874056175
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.659473874056175
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.055555600000000004	3.659473874056175
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.659473874056175
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.659473874056175
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.055555600000000004	3.659473874056175
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.659473874056175
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.055291361	3.6420683250744927
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.054021	3.558389039995763
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.053997199999999995	3.556821322642291
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.053997199999999995	3.556821322642291
EPILEPSY, PYRIDOXINE-DEPENDENT	0.05328043	3.5096073408167463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0528104	3.478646240495219
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.051479870999999996	3.3910036605541496
SNEDDON SYNDROME	0.051226251	3.3742975901681196
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.051226251	3.3742975901681196
MARSILI SYNDROME; MARSIS	0.0511509	3.369334183852933
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0511509	3.369334183852933
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0511509	3.369334183852933
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.051126	3.3676940089747207
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.05110501	3.366311387661722
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0503105	3.3139766349513495
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.049453751	3.257542169620694
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.1972212144039234
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.1972212144039234
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.047940861	3.157887383616748
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.046964	3.093541083548269
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.044461020000000004	2.928668596935126
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.0444434	2.9275079591297404
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.044117699999999996	2.9060539447589098
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.044117699999999996	2.9060539447589098
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.043667370999999996	2.876390558705481
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0432773	2.8506963958573266
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.042403371	2.7931302757311824
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.042403371	2.7931302757311824
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.042182860999999995	2.7786051768398345
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.042017109999999996	2.7676870794005364
FUMARASE DEFICIENCY; FMRD	0.04149941	2.7335859334386736
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.041206861	2.714315591252084
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.7021189478535055
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.0410217	2.7021189478535055
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0410217	2.7021189478535055
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.040817251	2.6886517946938433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0405229	2.6692627539076343
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.03874651	2.552251097204536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03874651	2.552251097204536
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0380161	2.504138642072211
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.037395371	2.463250926731741
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.037360751	2.460970490816733
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0372243	2.4519823983546085
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4324715630563585
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4324715630563585
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.036445	2.4006495355999626
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0363067	2.3915396486257965
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.035914009999999996	2.3656729709982827
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.034658361	2.282962772377716
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.034204609999999996	2.253073977551868
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.033923851	2.234580248289541
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0335738	2.211522221932392
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.211522221932392
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.033394361	2.1997024894034163
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.033173851	2.1851773905120693
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.033173851	2.1851773905120693
PHACE ASSOCIATION	0.033173851	2.1851773905120693
CYCLIC VOMITING SYNDROME	0.033173851	2.1851773905120693
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.033173851	2.1851773905120693
EPISODIC ATAXIA, TYPE 6	0.033173851	2.1851773905120693
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.033173851	2.1851773905120693
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.033173851	2.1851773905120693
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.033173851	2.1851773905120693
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.033173851	2.1851773905120693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.033091800000000005	2.179772652000737
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.032443161	2.137046491646174
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0322581	2.1248564352952983
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.0322581	2.1248564352952983
EPISODIC ATAXIA, TYPE 2	0.0322581	2.1248564352952983
STORMORKEN SYNDROME; STRMK	0.0322581	2.1248564352952983
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.0322581	2.1248564352952983
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.0322581	2.1248564352952983
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.0322581	2.1248564352952983
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.0322581	2.1248564352952983
PEROXISOME BIOGENESIS DISORDER 14B	0.0322581	2.1248564352952983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.031688400000000005	2.0873300245275312
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.031688400000000005	2.0873300245275312
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.031292270999999997	2.0612368183294874
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.031292270999999997	2.0612368183294874
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.031292270999999997	2.0612368183294874
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.031292270999999997	2.0612368183294874
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.031292270999999997	2.0612368183294874
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.031292270999999997	2.0612368183294874
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.031292270999999997	2.0612368183294874
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.031231210000000002	2.0572147011311546
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.030906009999999998	2.035793621998842
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.030906009999999998	2.035793621998842
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.030467351	2.0068989444124314
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.03037652	2.0009158631127173
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.03037652	2.0009158631127173
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9979108519503064
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9979108519503064
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.0303309	1.9979108519503064
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9979108519503064
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0303309	1.9979108519503064
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.030327550999999998	1.9976902517227102
GITELMAN SYNDROME	0.030327550999999998	1.9976902517227102
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.030327550999999998	1.9976902517227102
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.030327550999999998	1.9976902517227102
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.030327550999999998	1.9976902517227102
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.030327550999999998	1.9976902517227102
KRABBE DISEASE	0.030327550999999998	1.9976902517227102
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0297375	1.9588233108767703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0297375	1.9588233108767703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0297375	1.9588233108767703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0297375	1.9588233108767703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0297375	1.9588233108767703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0297375	1.9588233108767703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0297375	1.9588233108767703
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.029582871	1.9486378248830731
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.029582871	1.9486378248830731
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.029487151	1.942332702821127
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.029487151	1.942332702821127
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.029487151	1.942332702821127
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.029487151	1.942332702821127
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.029487151	1.942332702821127
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.029487151	1.942332702821127
CITRULLINEMIA, CLASSIC	0.029487151	1.942332702821127
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0294118	1.93736929650594
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0294118	1.93736929650594
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	1.93736929650594
STUVE-WIEDEMANN SYNDROME	0.0294118	1.93736929650594
IMMUNODEFICIENCY 61; IMD61	0.0294118	1.93736929650594
IMMUNODEFICIENCY 9; IMD9	0.0294118	1.93736929650594
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0294118	1.93736929650594
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	1.93736929650594
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.0294118	1.93736929650594
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	1.93736929650594
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.0294118	1.93736929650594
MAJEED SYNDROME	0.0294118	1.93736929650594
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0294118	1.93736929650594
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	1.93736929650594
DOHLE BODIES AND LEUKEMIA	0.0294118	1.93736929650594
IMMUNODEFICIENCY 10; IMD10	0.0294118	1.93736929650594
Yao syndrome	0.0294118	1.93736929650594
CAROLI DISEASE, ISOLATED	0.0294118	1.93736929650594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.028792660999999997	1.8965863152239582
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.02866712	1.8883168696663029
CARDIOMYOPATHY, DILATED, 1E	0.0285714	1.8820117476043567
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	1.8820117476043567
AMYLOIDOSIS VI	0.0285714	1.8820117476043567
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	1.8820117476043567
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.0285714	1.8820117476043567
WILLIAMS-BEUREN SYNDROME; WBS	0.0285714	1.8820117476043567
DERMOGRAPHISM, FAMILIAL	0.0285714	1.8820117476043567
SICKLE CELL ANEMIA	0.0285714	1.8820117476043567
PSEUDOXANTHOMA ELASTICUM; PXE	0.0285714	1.8820117476043567
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	1.8820117476043567
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	1.8820117476043567
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	0.0285714	1.8820117476043567
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0285714	1.8820117476043567
STROKE, ISCHEMIC	0.0285714	1.8820117476043567
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0285714	1.8820117476043567
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.0285714	1.8820117476043567
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0285714	1.8820117476043567
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0285714	1.8820117476043567
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.028445500000000002	1.8737186545454452
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.028442151	1.8734980543178494
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.028442151	1.8734980543178494
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.027876909999999998	1.8362653600071877
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.027820751	1.832566139887288
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.027820751	1.832566139887288
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.027820751	1.832566139887288
LETTERER-SIWE DISEASE	0.0275264	1.8131770991010785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0275264	1.8131770991010785
NAVAJO NEUROHEPATOPATHY	0.02747061	1.809502185187205
GLYCOGEN STORAGE DISEASE IB	0.02747061	1.809502185187205
GLYCOGEN STORAGE DISEASE IA	0.02747061	1.809502185187205
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.0264946	1.7452119408946845
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0264946	1.7452119408946845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0264946	1.7452119408946845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.0264946	1.7452119408946845
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.0264946	1.7452119408946845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.0264946	1.7452119408946845
MENTAL RETARDATION, X-LINKED 41	0.0263158	1.733434299600535
HAREL-YOON SYNDROME; HAYOS	0.0263158	1.733434299600535
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0263158	1.733434299600535
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.733434299600535
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0263158	1.733434299600535
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.733434299600535
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.733434299600535
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.02630383	1.7326458299904066
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.025549760999999997	1.6829749452418723
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.02536852	1.6710365141132766
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.02536852	1.6710365141132766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.02536852	1.6710365141132766
LIVER FAILURE, INFANTILE, TRANSIENT	0.02536852	1.6710365141132766
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.02536852	1.6710365141132766
RIBOFLAVIN DEFICIENCY	0.0251956	1.6596461912241025
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.024634009999999998	1.6226539900251018
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.024605851	1.6207991432622277
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.024009260999999997	1.5815014753669445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.024009260999999997	1.5815014753669445
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.024009260999999997	1.5815014753669445
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.02371491	1.5621124345807358
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.023547261	1.551069314976022
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0234375	1.5438393055460042
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.02325291	1.531680274189813
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.02325291	1.531680274189813
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023137951	1.5241078700201591
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.023137951	1.5241078700201591
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.023093509999999998	1.521180520150174
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.5116964888664404
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.5116964888664404
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.5116964888664404
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02294953	1.5116964888664404
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.5116964888664404
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.5116964888664404
NEUROFIBROMATOSIS, TYPE II	0.022654851	1.4922858425637633
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.022654851	1.4922858425637633
PARIETAL FORAMINA	0.022654851	1.4922858425637633
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.022654851	1.4922858425637633
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.022654851	1.4922858425637633
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.022654851	1.4922858425637633
PAPILLOMA OF CHOROID PLEXUS	0.022654851	1.4922858425637633
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.022654851	1.4922858425637633
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.022654851	1.4922858425637633
CRANIOSYNOSTOSIS 2	0.022654851	1.4922858425637633
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	0.02263151	1.4907483597592512
#610773 MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY;;MPCD	0.02263151	1.4907483597592512
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.022283261000000002	1.4678090320017223
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.022283261000000002	1.4678090320017223
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.022283261000000002	1.4678090320017223
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.0222222	1.4637869148033884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.0222222	1.4637869148033884
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.0222222	1.4637869148033884
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.4637869148033884
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4637869148033884
EPILEPSY, HOT WATER, 1	0.0222222	1.4637869148033884
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4637869148033884
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4637869148033884
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0222222	1.4637869148033884
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4637869148033884
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0217391	1.4319648873469928
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.0217391	1.4319648873469928
BRUNNER SYNDROME; BRNRS	0.0217391	1.4319648873469928
GLUTAMATE MONOSODIUM SENSITIVITY	0.0217391	1.4319648873469928
EPISODIC ATAXIA, TYPE 3	0.0217391	1.4319648873469928
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.0217391	1.4319648873469928
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.0217391	1.4319648873469928
HYPER-IGD SYNDROME	0.0217391	1.4319648873469928
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.0217391	1.4319648873469928
CAMURATI-ENGELMANN DISEASE	0.0217391	1.4319648873469928
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0217391	1.4319648873469928
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0217391	1.4319648873469928
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.0217391	1.4319648873469928
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0217391	1.4319648873469928
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0217391	1.4319648873469928
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0217391	1.4319648873469928
CHIARI MALFORMATION TYPE I	0.0217391	1.4319648873469928
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0217391	1.4319648873469928
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0217391	1.4319648873469928
SCLEROSTEOSIS 1; SOST1	0.0217391	1.4319648873469928
EPISODIC ATAXIA, TYPE 1; EA1	0.0217391	1.4319648873469928
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0217391	1.4319648873469928
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0217391	1.4319648873469928
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.021367510000000003	1.4074880767849518
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.021367510000000003	1.4074880767849518
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.020794360999999997	1.3697344787418841
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.020794360999999997	1.3697344787418841
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.020794360999999997	1.3697344787418841
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.020633000000000002	1.359105552696777
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.020573861	1.3552100385553074
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.020332361	1.3393023183509616
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.019839350999999998	1.3068275144671329
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.019839350999999998	1.3068275144671329
HYPERPROLINEMIA, TYPE I	0.019783651	1.3031585288961927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01965811	1.2948890833385371
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.0189236	1.2465065592503624
GLYCOGEN STORAGE DISEASE VI	0.0189236	1.2465065592503624
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.0189236	1.2465065592503624
TYROSINEMIA, TYPE I; TYRSN1	0.0189236	1.2465065592503624
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.0189236	1.2465065592503624
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0189236	1.2465065592503624
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0188679	1.2428375736794222
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2428375736794222
ERYTHERMALGIA, PRIMARY	0.0188679	1.2428375736794222
TRANSSEXUALITY	0.0188679	1.2428375736794222
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2428375736794222
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2428375736794222
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.2428375736794222
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.2428375736794222
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.2428375736794222
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2428375736794222
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.0188679	1.2428375736794222
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2428375736794222
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2428375736794222
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2428375736794222
CARDIAC ARRHYTHMIA	0.0188679	1.2428375736794222
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2428375736794222
BETA-UREIDOPROPIONASE DEFICIENCY	0.0188679	1.2428375736794222
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0188679	1.2428375736794222
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2428375736794222
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2428375736794222
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2428375736794222
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2428375736794222
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2428375736794222
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2428375736794222
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2428375736794222
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0188679	1.2428375736794222
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2428375736794222
THUMBS, CONGENITAL CLASPED	0.0188679	1.2428375736794222
269800 SENILE PLAQUE FORMATION	0.0188679	1.2428375736794222
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2428375736794222
ALCOHOL DEPENDENCE	0.0188679	1.2428375736794222
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.0188679	1.2428375736794222
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2428375736794222
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.0188679	1.2428375736794222
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2428375736794222
CERVICAL RIB	0.0188679	1.2428375736794222
RING CHROMOSOME 14 SYNDROME	0.0188679	1.2428375736794222
DIASTEMATOMYELIA	0.0188679	1.2428375736794222
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.0188679	1.2428375736794222
MOTION SICKNESS	0.0188679	1.2428375736794222
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2428375736794222
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0188679	1.2428375736794222
RHEUMATOID ARTHRITIS	0.0188679	1.2428375736794222
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2428375736794222
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2428375736794222
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2428375736794222
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2428375736794222
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2428375736794222
MYOPATHY, CONGENITAL	0.0188679	1.2428375736794222
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2428375736794222
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2428375736794222
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2428375736794222
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2428375736794222
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.2428375736794222
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2428375736794222
PALMOMENTAL REFLEX	0.0188679	1.2428375736794222
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.2428375736794222
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	1.2375435634399883
LEIGH SYNDROME; LS	0.018471770999999998	1.216744367481379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.018471770999999998	1.216744367481379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.018471770999999998	1.216744367481379
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.018471770999999998	1.216744367481379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.018471770999999998	1.216744367481379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.018471770999999998	1.216744367481379
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.018471770999999998	1.216744367481379
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018471770999999998	1.216744367481379
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.017737260999999997	1.1683618433932041
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.01755602	1.1564234122646084
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.01755602	1.1564234122646084
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.01755602	1.1564234122646084
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.01755602	1.1564234122646084
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.01755602	1.1564234122646084
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.01755602	1.1564234122646084
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.01755602	1.1564234122646084
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.01755602	1.1564234122646084
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.01755602	1.1564234122646084
PSEUDO-TORCH SYNDROME 2	0.017275261	1.1379296830022816
INFANTILE LIVER FAILURE SYNDROME 1	0.017275261	1.1379296830022816
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.016821509999999998	1.1080408881764336
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.016821509999999998	1.1080408881764336
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.0895471589141068
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.016540751	1.0895471589141068
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	1.029226203697336
HYDROXYLYSINURIA	0.015625	1.029226203697336
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	1.029226203697336
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.029226203697336
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.029226203697336
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.015625	1.029226203697336
CARNOSINEMIA	0.015625	1.029226203697336
PAINE SYNDROME	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.029226203697336
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.029226203697336
ROIFMAN-CHITAYAT SYNDROME	0.015625	1.029226203697336
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.015625	1.029226203697336
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	1.029226203697336
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.015625	1.029226203697336
MICROHYDRANENCEPHALY; MHAC	0.015625	1.029226203697336
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	1.029226203697336
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.015625	1.029226203697336
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.015625	1.029226203697336
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.015625	1.029226203697336
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.015621650999999999	1.0290056034697406
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.0290056034697406
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.0290056034697406
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.015621650999999999	1.0290056034697406
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.015621650999999999	1.0290056034697406
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.015621650999999999	1.0290056034697406
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.015621650999999999	1.0290056034697406
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.015621650999999999	1.0290056034697406
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.015621650999999999	1.0290056034697406
HYPOPHOSPHATASIA, INFANTILE	0.015621650999999999	1.0290056034697406
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.015000251	0.9880736890391789
SUDDEN CARDIAC FAILURE, INFANTILE	0.015000251	0.9880736890391789
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.015000251	0.9880736890391789
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.015000251	0.9880736890391789
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.015000251	0.9880736890391789
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.015000251	0.9880736890391789
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.015000251	0.9880736890391789
CIRRHOSIS, FAMILIAL	0.0147059	0.96868464825297
RAGWEED SENSITIVITY	0.0147059	0.96868464825297
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.96868464825297
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0147059	0.96868464825297
HALLERMANN-STREIFF SYNDROME; HSS	0.0147059	0.96868464825297
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.96868464825297
GLYCOGEN STORAGE DISEASE II	0.0147059	0.96868464825297
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.96868464825297
CAFFEY DISEASE	0.0147059	0.96868464825297
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.96868464825297
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.96868464825297
CYCLIC NEUTROPENIA	0.0147059	0.96868464825297
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.96868464825297
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0147059	0.96868464825297
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.96868464825297
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.96868464825297
RHABDOMYOLYSIS, ACUTE RECURRENT	0.0147059	0.96868464825297
PANCREATITIS, HEREDITARY	0.0147059	0.96868464825297
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0147059	0.96868464825297
NEUROPATHY, PAINFUL	0.0147059	0.96868464825297
PELGER-HUET ANOMALY; PHA	0.0147059	0.96868464825297
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.96868464825297
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.0147059	0.96868464825297
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.0147059	0.96868464825297
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.0147059	0.96868464825297
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0147059	0.96868464825297
DYSTONIA 12; DYT12	0.0147059	0.96868464825297
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.96868464825297
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.96868464825297
PSORIASIS 14, PUSTULAR	0.0147059	0.96868464825297
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.96868464825297
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.0147059	0.96868464825297
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0147059	0.96868464825297
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0147059	0.96868464825297
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0147059	0.96868464825297
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.96868464825297
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.0147059	0.96868464825297
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.0147059	0.96868464825297
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.96868464825297
STIFF-PERSON SYNDROME; SPS	0.0147059	0.96868464825297
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.0147059	0.96868464825297
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.96868464825297
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.96868464825297
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.0147059	0.96868464825297
CINCA SYNDROME; CINCA	0.0147059	0.96868464825297
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.96868464825297
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.96868464825297
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.0147059	0.96868464825297
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0147059	0.96868464825297
HALOTHANE HEPATITIS	0.0147059	0.96868464825297
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.0147059	0.96868464825297
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0147059	0.96868464825297
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.96868464825297
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0147059	0.96868464825297
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.96868464825297
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.0147059	0.96868464825297
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.96868464825297
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.0147059	0.96868464825297
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.0147059	0.96868464825297
IMMUNODEFICIENCY 32B; IMD32B	0.0147059	0.96868464825297
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.0140845	0.9277527338224085
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.0140845	0.9277527338224085
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.0140845	0.9277527338224085
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.0140845	0.9277527338224085
HAWKINSINURIA	0.0140845	0.9277527338224085
LACTASE DEFICIENCY, CONGENITAL	0.0140845	0.9277527338224085
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.0140845	0.9277527338224085
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.0140845	0.9277527338224085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0140845	0.9277527338224085
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0140845	0.9277527338224085
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.0140845	0.9277527338224085
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.0140845	0.9277527338224085
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0140845	0.9277527338224085
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.013736251000000001	0.9048134060648795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.013736251000000001	0.9048134060648795
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.013736251000000001	0.9048134060648795
GLUTAMINE DEFICIENCY, CONGENITAL	0.013736251000000001	0.9048134060648795
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.013736251000000001	0.9048134060648795
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.013736251000000001	0.9048134060648795
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.013736251000000001	0.9048134060648795
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.013736251000000001	0.9048134060648795
GLYCINE ENCEPHALOPATHY; GCE	0.013736251000000001	0.9048134060648795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.013736251000000001	0.9048134060648795
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.013736251000000001	0.9048134060648795
CROME SYNDROME	0.013736251000000001	0.9048134060648795
PITT-HOPKINS SYNDROME	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.013736251000000001	0.9048134060648795
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.013736251000000001	0.9048134060648795
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.013736251000000001	0.9048134060648795
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.013736251000000001	0.9048134060648795
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.013736251000000001	0.9048134060648795
HYPEREKPLEXIA 4; HKPX4	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.013736251000000001	0.9048134060648795
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.013736251000000001	0.9048134060648795
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.012820500000000002	0.8444924508481089
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.012820500000000002	0.8444924508481089
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.012820500000000002	0.8444924508481089
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.012820500000000002	0.8444924508481089
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.012820500000000002	0.8444924508481089
IMMUNODEFICIENCY 44	0.012820500000000002	0.8444924508481089
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.012820500000000002	0.8444924508481089
SHASHI-PENA SYNDROME; SHAPNS	0.012026851	0.7922144126184647
MIRAGE SYNDROME; MIRAGE	0.012026851	0.7922144126184647
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.012026851	0.7922144126184647
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.012026851	0.7922144126184647
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.012026851	0.7922144126184647
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.012026851	0.7922144126184647
MEHMO SYNDROME; MEHMO	0.012026851	0.7922144126184647
HOLOPROSENCEPHALY 1; HPE1	0.012026851	0.7922144126184647
HYPOADRENOCORTICISM, FAMILIAL	0.012026851	0.7922144126184647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.012026851	0.7922144126184647
FRUCTOSE AND GALACTOSE INTOLERANCE	0.012026851	0.7922144126184647
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.012026851	0.7922144126184647
SMITH-KINGSMORE SYNDROME; SKS	0.012026851	0.7922144126184647
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.012026851	0.7922144126184647
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.012026851	0.7922144126184647
VISCERAL STEATOSIS, CONGENITAL	0.012026851	0.7922144126184647
TENORIO SYNDROME; TNORS	0.012026851	0.7922144126184647
TIMOTHY SYNDROME; TS	0.012026851	0.7922144126184647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.011785351	0.7763066924141188
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.011785351	0.7763066924141188
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.011785351	0.7763066924141188
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.011785351	0.7763066924141188
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.011785351	0.7763066924141188
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.011785351	0.7763066924141188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.011785351	0.7763066924141188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.011785351	0.7763066924141188
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011785351	0.7763066924141188
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.011785351	0.7763066924141188
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.011785351	0.7763066924141188
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.011785351	0.7763066924141188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.011785351	0.7763066924141188
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.011785351	0.7763066924141188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.011785351	0.7763066924141188
Growth hormone deficiency, isolated, type IA	0.0111111	0.7318934574016942
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.0111111	0.7318934574016942
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.0111111	0.7318934574016942
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0111111	0.7318934574016942
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.0111111	0.7318934574016942
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0111111	0.7318934574016942
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0111111	0.7318934574016942
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0111111	0.7318934574016942
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.0111111	0.7318934574016942
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.0111111	0.7318934574016942
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0111111	0.7318934574016942
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0111111	0.7318934574016942
COSTELLO SYNDROME; CSTLO	0.0111111	0.7318934574016942
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0111111	0.7318934574016942
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0111111	0.7318934574016942
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0111111	0.7318934574016942
HEMOCHROMATOSIS, NEONATAL	0.0111111	0.7318934574016942
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0108696	0.7159857371973481
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0108696	0.7159857371973481
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0108696	0.7159857371973481
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0108696	0.7159857371973481
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.009924760999999999	0.6537487415445361
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.009924760999999999	0.6537487415445361
PERRAULT SYNDROME 5; PRLTS5	0.009924760999999999	0.6537487415445361
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009924760999999999	0.6537487415445361
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.009924760999999999	0.6537487415445361
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.009924760999999999	0.6537487415445361
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.009924760999999999	0.6537487415445361
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009924760999999999	0.6537487415445361
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.009924760999999999	0.6537487415445361
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009462761	0.6233165811536134
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.009462761	0.6233165811536134
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.009462761	0.6233165811536134
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009462761	0.6233165811536134
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.009462761	0.6233165811536134
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.009462761	0.6233165811536134
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.009462761	0.6233165811536134
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.009462761	0.6233165811536134
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.009462761	0.6233165811536134
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.009462761	0.6233165811536134
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.009462761	0.6233165811536134
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00900901	0.5934277863277657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00900901	0.5934277863277657
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00900901	0.5934277863277657
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00900901	0.5934277863277657
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00900901	0.5934277863277657
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00900901	0.5934277863277657
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00900901	0.5934277863277657
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00900901	0.5934277863277657
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00900901	0.5934277863277657
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00900901	0.5934277863277657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00900901	0.5934277863277657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00900901	0.5934277863277657
LEBER OPTIC ATROPHY AND DYSTONIA	0.00900901	0.5934277863277657
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00900901	0.5934277863277657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00900901	0.5934277863277657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00900901	0.5934277863277657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00900901	0.5934277863277657
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00900901	0.5934277863277657
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00900901	0.5934277863277657
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00900901	0.5934277863277657
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00900901	0.5934277863277657
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00900901	0.5934277863277657
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.008728251	0.5749340570654387
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.008728251	0.5749340570654387
RETINITIS PIGMENTOSA 59; RP59	0.008728251	0.5749340570654387
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008728251	0.5749340570654387
LATHOSTEROLOSIS	0.008728251	0.5749340570654387
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.008728251	0.5749340570654387
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.008728251	0.5749340570654387
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.008728251	0.5749340570654387
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.008728251	0.5749340570654387
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.008728251	0.5749340570654387
PREECLAMPSIA/ECLAMPSIA 1	0.008728251	0.5749340570654387
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.008728251	0.5749340570654387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.008728251	0.5749340570654387
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.008728251	0.5749340570654387
COACH SYNDROME	0.008728251	0.5749340570654387
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.008728251	0.5749340570654387
IMMUNODEFICIENCY 47	0.008728251	0.5749340570654387
PHENFORMIN 4-HYDROXYLATION	0.00854701	0.5629956259368429
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00854701	0.5629956259368429
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00854701	0.5629956259368429
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00854701	0.5629956259368429
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00854701	0.5629956259368429
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00854701	0.5629956259368429
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	0.00854701	0.5629956259368429
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00854701	0.5629956259368429
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00854701	0.5629956259368429
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00854701	0.5629956259368429
SUCCINIC ACIDEMIA	0.00854701	0.5629956259368429
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00854701	0.5629956259368429
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00854701	0.5629956259368429
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00854701	0.5629956259368429
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00854701	0.5629956259368429
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.00854701	0.5629956259368429
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00854701	0.5629956259368429
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00854701	0.5629956259368429
HEMOCHROMATOSIS, TYPE 2B	0.0078125	0.514613101848668
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0078125	0.514613101848668
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.0078125	0.514613101848668
SCLEROSING CHOLANGITIS, NEONATAL	0.0078125	0.514613101848668
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.0078125	0.514613101848668
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.0078125	0.514613101848668
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.0078125	0.514613101848668
Lipodystrophy, congenital generalized, type 2	0.0078125	0.514613101848668
#600803 GALLBLADDER DISEASE 1; GBD1;;CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED; LPAC	0.0078125	0.514613101848668
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.0078125	0.514613101848668
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.0078125	0.514613101848668
#300752 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP;;PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT; XLDPP;;ERYTHROHEPATIC PROTOPORPHYRIA, X-LINKED;	0.0078125	0.514613101848668
XFE PROGEROID SYNDROME; XFEPS	0.0078125	0.514613101848668
RETINITIS PIGMENTOSA 71; RP71	0.0078125	0.514613101848668
MEVALONIC ACIDURIA; MEVA	0.0078125	0.514613101848668
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0078125	0.514613101848668
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.0078125	0.514613101848668
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.0078125	0.514613101848668
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.0078125	0.514613101848668
BARDET-BIEDL SYNDROME 21; BBS21	0.0078125	0.514613101848668
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.0078125	0.514613101848668
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0078125	0.514613101848668
HARDIKAR SYNDROME	0.0078125	0.514613101848668
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0078125	0.514613101848668
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.0078125	0.514613101848668
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0078125	0.514613101848668
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.0078125	0.514613101848668
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0078125	0.514613101848668
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.0078125	0.514613101848668
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.0078125	0.514613101848668
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.0078125	0.514613101848668
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.0078125	0.514613101848668
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.0078125	0.514613101848668
REYNOLDS SYNDROME	0.0078125	0.514613101848668
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.0078125	0.514613101848668
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0078125	0.514613101848668
Lipodystrophy, congenital generalized, type 1	0.0078125	0.514613101848668
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0078125	0.514613101848668
HEMOCHROMATOSIS, TYPE 1	0.0078125	0.514613101848668
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0078125	0.514613101848668
ALSTROM SYNDROME; ALMS	0.0078125	0.514613101848668
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.0078125	0.514613101848668
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0078125	0.514613101848668
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004997381	0.3291798704037887
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004997381	0.3291798704037887
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004997381	0.3291798704037887
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004997381	0.3291798704037887
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.3291798704037887
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004997381	0.3291798704037887
EMANUEL SYNDROME	0.004997381	0.3291798704037887
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004997381	0.3291798704037887
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004997381	0.3291798704037887
XYLOSIDASE DEFICIENCY	0.004997381	0.3291798704037887
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.3291798704037887
ASPARTYLGLUCOSAMINURIA; AGU	0.004997381	0.3291798704037887
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.004997381	0.3291798704037887
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004997381	0.3291798704037887
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004997381	0.3291798704037887
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004997381	0.3291798704037887
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.004997381	0.3291798704037887
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.004997381	0.3291798704037887
CHROMOSOME 10Q26 DELETION SYNDROME	0.004997381	0.3291798704037887
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.004997381	0.3291798704037887
SALLA DISEASE	0.004997381	0.3291798704037887
EPILEPSY-TELANGIECTASIA	0.004997381	0.3291798704037887
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004997381	0.3291798704037887
GAPO SYNDROME; GAPOS	0.004997381	0.3291798704037887
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.004997381	0.3291798704037887
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.3291798704037887
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004997381	0.3291798704037887
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004997381	0.3291798704037887
TRISOMY 18-LIKE SYNDROME	0.00408163	0.26885891518701815
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.26885891518701815
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.26885891518701815
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.26885891518701815
CEPHALIN LIPIDOSIS	0.00408163	0.26885891518701815
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.26885891518701815
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.26885891518701815
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.26885891518701815
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.26885891518701815
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.26885891518701815
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.26885891518701815
DELETED IN AZOOSPERMIA	0.00408163	0.26885891518701815
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.26885891518701815
ALKAPTONURIA	0.00408163	0.26885891518701815
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.26885891518701815
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.26885891518701815
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.26885891518701815
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.26885891518701815
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00408163	0.26885891518701815
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.26885891518701815
PITUITARY DWARFISM IV	0.00408163	0.26885891518701815
PENDRED SYNDROME	0.00408163	0.26885891518701815
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.26885891518701815
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.26885891518701815
BEETURIA	0.00408163	0.26885891518701815
AREDYLD	0.00408163	0.26885891518701815
PYGMY	0.00408163	0.26885891518701815
HOOFT DISEASE	0.00408163	0.26885891518701815
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.26885891518701815
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.26885891518701815
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.26885891518701815
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.26885891518701815
HEINZ BODY ANEMIAS	0.00408163	0.26885891518701815
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.26885891518701815
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.26885891518701815
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.26885891518701815
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.26885891518701815
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.26885891518701815
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.26885891518701815
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.26885891518701815
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.26885891518701815
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.26885891518701815
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.26885891518701815
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.26885891518701815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.26885891518701815
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.26885891518701815
ICHTHYOSIS, X-LINKED	0.00408163	0.26885891518701815
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.26885891518701815
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.26885891518701815
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.26885891518701815
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.26885891518701815
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00408163	0.26885891518701815
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.26885891518701815
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.26885891518701815
FLOOD FACTOR DEFICIENCY	0.00408163	0.26885891518701815
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.26885891518701815
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.26885891518701815
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.26885891518701815
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.26885891518701815
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.26885891518701815
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.26885891518701815
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00408163	0.26885891518701815
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.26885891518701815
SCHIZOPHRENIA 4	0.00408163	0.26885891518701815
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.26885891518701815
HYPERPROGLUCAGONEMIA	0.00408163	0.26885891518701815
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00408163	0.26885891518701815
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.26885891518701815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.26885891518701815
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.26885891518701815
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.26885891518701815
GLUTATHIONE REDUCTASE	0.00408163	0.26885891518701815
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.26885891518701815
GONADOBLASTOMA	0.00408163	0.26885891518701815
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.26885891518701815
OVARIAN CANCER	0.00408163	0.26885891518701815
GLOMUVENOUS MALFORMATIONS	0.00408163	0.26885891518701815
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.26885891518701815
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.26885891518701815
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.26885891518701815
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.26885891518701815
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.26885891518701815
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.26885891518701815
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.26885891518701815
COUMARIN RESISTANCE	0.00408163	0.26885891518701815
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.26885891518701815
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.26885891518701815
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.26885891518701815
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.26885891518701815
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.26885891518701815
LARON SYNDROME	0.00408163	0.26885891518701815
PREMATURE OVARIAN FAILURE 1	0.00408163	0.26885891518701815
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.26885891518701815
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.26885891518701815
PROGESTERONE RESISTANCE	0.00408163	0.26885891518701815
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.26885891518701815
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.26885891518701815
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.26885891518701815
MACROCYTOSIS, FAMILIAL	0.00408163	0.26885891518701815
PACMAN DYSPLASIA	0.00408163	0.26885891518701815
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.26885891518701815
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.26885891518701815
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.26885891518701815
CITRULLINE TRANSPORT DEFECT	0.00408163	0.26885891518701815
REVESZ SYNDROME	0.00408163	0.26885891518701815
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.26885891518701815
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.26885891518701815
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.26885891518701815
ALAND ISLAND EYE DISEASE	0.00408163	0.26885891518701815
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.26885891518701815
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.26885891518701815
NEPHROSIALIDOSIS	0.00408163	0.26885891518701815
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.26885891518701815
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.26885891518701815
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.26885891518701815
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.26885891518701815
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00408163	0.26885891518701815
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.26885891518701815
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.26885891518701815
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.26885891518701815
HYPOASCORBEMIA	0.00408163	0.26885891518701815
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.26885891518701815
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.26885891518701815
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.26885891518701815
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00408163	0.26885891518701815
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.26885891518701815
XM SYSTEM	0.00408163	0.26885891518701815
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.26885891518701815
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.26885891518701815
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.26885891518701815
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.26885891518701815
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.26885891518701815
APOLIPOPROTEIN(A)	0.00408163	0.26885891518701815
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.26885891518701815
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.26885891518701815
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.26885891518701815
ZINC, ELEVATED PLASMA	0.00408163	0.26885891518701815
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.26885891518701815
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.26885891518701815
LARSEN-LIKE SYNDROME	0.00408163	0.26885891518701815
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.26885891518701815
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.26885891518701815
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.26885891518701815
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.26885891518701815
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.26885891518701815
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.26885891518701815
MYOPATHY, SPHEROID BODY	0.00408163	0.26885891518701815
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.26885891518701815
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.26885891518701815
ONCOCYTOMA	0.00408163	0.26885891518701815
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.26885891518701815
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.26885891518701815
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.26885891518701815
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.26885891518701815
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00408163	0.26885891518701815
#170100 PROLIDASE DEFICIENCY	0.00408163	0.26885891518701815
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.26885891518701815
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.26885891518701815
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.26885891518701815
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.26885891518701815
CALVARIAL HYPEROSTOSIS	0.00408163	0.26885891518701815
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.26885891518701815
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.26885891518701815
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.26885891518701815
ETHANOLAMINOSIS	0.00408163	0.26885891518701815
T-SUBSTANCE ANOMALY	0.00408163	0.26885891518701815
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.26885891518701815
XANTHINURIA, TYPE I	0.00408163	0.26885891518701815
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.26885891518701815
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.26885891518701815
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.26885891518701815
OSTEOGENIC SARCOMA	0.00408163	0.26885891518701815
SPINAL ARACHNOIDITIS	0.00408163	0.26885891518701815
CARBOXYLESTERASE 1	0.00408163	0.26885891518701815
LIPASE DEFICIENCY, COMBINED	0.00408163	0.26885891518701815
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.26885891518701815
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.26885891518701815
DERMATOLEUKODYSTROPHY	0.00408163	0.26885891518701815
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.26885891518701815
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.26885891518701815
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.26885891518701815
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.26885891518701815
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.26885891518701815
GLUTATHIONURIA	0.00408163	0.26885891518701815
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.26885891518701815
LYMPHOKINE DEFICIENCY	0.00408163	0.26885891518701815
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00408163	0.26885891518701815
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.26885891518701815
FINGERPRINT BODY MYOPATHY	0.00408163	0.26885891518701815
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.26885891518701815
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.26885891518701815
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.26885891518701815
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.26885891518701815
PARAOXONASE 1	0.00408163	0.26885891518701815
PERRY SYNDROME	0.00408163	0.26885891518701815
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.26885891518701815
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.26885891518701815
ACETYLATION, SLOW	0.00408163	0.26885891518701815
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.26885891518701815
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.26885891518701815
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.26885891518701815
DERMATITIS, ATOPIC	0.00408163	0.26885891518701815
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.26885891518701815
SCHINDLER DISEASE, TYPE I	0.000915751	0.060320955216770514
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000915751	0.060320955216770514
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000915751	0.060320955216770514
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.060320955216770514
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000915751	0.060320955216770514
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.060320955216770514
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.060320955216770514
THYROCEREBRORETINAL SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000915751	0.060320955216770514
LISSENCEPHALY 5; LIS5	0.000915751	0.060320955216770514
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.060320955216770514
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.060320955216770514
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.060320955216770514
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.060320955216770514
HEART AND BRAIN MALFORMATION SYNDROME	0.000915751	0.060320955216770514
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.060320955216770514
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.060320955216770514
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000915751	0.060320955216770514
COFFIN-SIRIS SYNDROME 4; CSS4	0.000915751	0.060320955216770514
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.060320955216770514
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000915751	0.060320955216770514
TAY-SACHS DISEASE; TSD	0.000915751	0.060320955216770514
BOHRING-OPITZ SYNDROME	0.000915751	0.060320955216770514
NIEMANN-PICK DISEASE, TYPE C2	0.000915751	0.060320955216770514
Wolf-Hirschhorn Syndrome	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000915751	0.060320955216770514
CHROMOSOME 18Q DELETION SYNDROME	0.000915751	0.060320955216770514
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000915751	0.060320955216770514
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 9	0.000915751	0.060320955216770514
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000915751	0.060320955216770514
CHROMOSOME 5Q12 DELETION SYNDROME	0.000915751	0.060320955216770514
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.060320955216770514
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.060320955216770514
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000915751	0.060320955216770514
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000915751	0.060320955216770514
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000915751	0.060320955216770514
ADAMS-OLIVER SYNDROME 2; AOS2	0.000915751	0.060320955216770514
KBG SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 72	0.000915751	0.060320955216770514
COFFIN-SIRIS SYNDROME 3; CSS3	0.000915751	0.060320955216770514
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.060320955216770514
DYSOSTEOSCLEROSIS	0.000915751	0.060320955216770514
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000915751	0.060320955216770514
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000915751	0.060320955216770514
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.060320955216770514
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000915751	0.060320955216770514
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.060320955216770514
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.060320955216770514
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.060320955216770514
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.060320955216770514
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.060320955216770514
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000915751	0.060320955216770514
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.060320955216770514
CATEL-MANZKE SYNDROME; CATMANS	0.000915751	0.060320955216770514
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.060320955216770514
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.000915751	0.060320955216770514
Muenke syndrome	0.000915751	0.060320955216770514
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.060320955216770514
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000915751	0.060320955216770514
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.060320955216770514
PHELAN-MCDERMID SYNDROME; PHMDS	0.000915751	0.060320955216770514
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.060320955216770514
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000915751	0.060320955216770514
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000915751	0.060320955216770514
GURRIERI SYNDROME	0.000915751	0.060320955216770514
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000915751	0.060320955216770514
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000915751	0.060320955216770514
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.000915751	0.060320955216770514
ALEXANDER DISEASE	0.000915751	0.060320955216770514
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.060320955216770514
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.060320955216770514
FRYNS SYNDROME; FRNS	0.000915751	0.060320955216770514
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000915751	0.060320955216770514
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000915751	0.060320955216770514
RETT SYNDROME; RTT	0.000915751	0.060320955216770514
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000915751	0.060320955216770514
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.060320955216770514
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000915751	0.060320955216770514
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.060320955216770514
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.060320955216770514
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000915751	0.060320955216770514
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.060320955216770514
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000915751	0.060320955216770514
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.060320955216770514
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.060320955216770514
LISSENCEPHALY 4	0.000915751	0.060320955216770514
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.060320955216770514
KETOADIPICACIDURIA	0.000915751	0.060320955216770514
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000915751	0.060320955216770514
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.060320955216770514
DARIER-WHITE DISEASE; DAR	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000915751	0.060320955216770514
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000915751	0.060320955216770514
MARDEN-WALKER SYNDROME	0.000915751	0.060320955216770514
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.000915751	0.060320955216770514
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000915751	0.060320955216770514
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.060320955216770514
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.060320955216770514
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000915751	0.060320955216770514
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000915751	0.060320955216770514
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000915751	0.060320955216770514
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000915751	0.060320955216770514
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.060320955216770514
SULFOCYSTEINURIA	0.000915751	0.060320955216770514
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.060320955216770514
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000915751	0.060320955216770514
KOOLEN-DE VRIES SYNDROME; KDVS	0.000915751	0.060320955216770514
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000915751	0.060320955216770514
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000915751	0.060320955216770514
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.060320955216770514
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.060320955216770514
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.060320955216770514
OCULOECTODERMAL SYNDROME; OES	0.000915751	0.060320955216770514
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000915751	0.060320955216770514
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.060320955216770514
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000915751	0.060320955216770514
PETTIGREW SYNDROME	0.000915751	0.060320955216770514
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.060320955216770514
CHROMOSOME 16p13.3 DELETION SYNDROME	0.000915751	0.060320955216770514
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.060320955216770514
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000915751	0.060320955216770514
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000915751	0.060320955216770514
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.060320955216770514
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000915751	0.060320955216770514
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000915751	0.060320955216770514
LISSENCEPHALY 3; LIS3	0.000915751	0.060320955216770514
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.060320955216770514
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000915751	0.060320955216770514
HHHH SYNDROME	0.000915751	0.060320955216770514
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000915751	0.060320955216770514
LUSCAN-LUMISH SYNDROME; LLS	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.060320955216770514
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 49; IMD49	0.000915751	0.060320955216770514
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000915751	0.060320955216770514
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000915751	0.060320955216770514
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000915751	0.060320955216770514
15q13.3 microdeletion syndrome	0.000915751	0.060320955216770514
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000915751	0.060320955216770514
CORNELIA DE LANGE SYNDROME 3	0.000915751	0.060320955216770514
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000915751	0.060320955216770514
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.060320955216770514
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.060320955216770514
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.060320955216770514
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.060320955216770514
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.060320955216770514
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.060320955216770514
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000915751	0.060320955216770514
ADENYLOSUCCINASE DEFICIENCY	0.000915751	0.060320955216770514
CHROMOSOME 2q37 DELETION SYNDROME	0.000915751	0.060320955216770514
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.060320955216770514
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.060320955216770514
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.000915751	0.060320955216770514
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000915751	0.060320955216770514
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000915751	0.060320955216770514
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.060320955216770514
OHDO SYNDROME	0.000915751	0.060320955216770514
SCHAAF-YANG SYNDROME; SHFYNG	0.000915751	0.060320955216770514
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.060320955216770514
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000915751	0.060320955216770514
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.060320955216770514
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000915751	0.060320955216770514
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000915751	0.060320955216770514
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.060320955216770514
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.060320955216770514
KAGAMI-OGATA SYNDROME	0.000915751	0.060320955216770514
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.000915751	0.060320955216770514
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000915751	0.060320955216770514
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000915751	0.060320955216770514
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.000915751	0.060320955216770514
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.060320955216770514
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000915751	0.060320955216770514
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000915751	0.060320955216770514
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000915751	0.060320955216770514
KLEEFSTRA SYNDROME	0.000915751	0.060320955216770514
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.060320955216770514
HOLOPROSENCEPHALY 7	0.000915751	0.060320955216770514
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.060320955216770514
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000915751	0.060320955216770514
Glycosylphosphatidylinositol biosynthesis defect 18	0.000915751	0.060320955216770514
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.060320955216770514
HARTNUP DISORDER	0.000915751	0.060320955216770514
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.060320955216770514
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000915751	0.060320955216770514
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000915751	0.060320955216770514
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.060320955216770514
ELEJALDE DISEASE	0.000915751	0.060320955216770514
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.060320955216770514
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000915751	0.060320955216770514
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000915751	0.060320955216770514
JOUBERT SYNDROME 30; JBTS30	0.000915751	0.060320955216770514
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000915751	0.060320955216770514
PAPILLORENAL SYNDROME	0.000915751	0.060320955216770514
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.060320955216770514
PERRAULT SYNDROME 3	0.000915751	0.060320955216770514
SECKEL SYNDROME 7; SCKL7	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.060320955216770514
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000915751	0.060320955216770514
HYPERPROLINEMIA, TYPE II	0.000915751	0.060320955216770514
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.060320955216770514
GABA-TRANSAMINASE DEFICIENCY	0.000915751	0.060320955216770514
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000915751	0.060320955216770514
SMITH-MAGENIS SYNDROME; SMS	0.000915751	0.060320955216770514
OROFACIODIGITAL SYNDROME I; OFD1	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 88	0.000915751	0.060320955216770514
AUTISM	0.000915751	0.060320955216770514
PALLISTER-HALL SYNDROME	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.060320955216770514
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000915751	0.060320955216770514
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000915751	0.060320955216770514
COCKAYNE SYNDROME A; CSA	0.000915751	0.060320955216770514
Pierpont syndrome	0.000915751	0.060320955216770514
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.060320955216770514
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000915751	0.060320955216770514
INCONTINENTIA PIGMENTI; IP	0.000915751	0.060320955216770514
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000915751	0.060320955216770514
BAND HETEROTOPIA; BH	0.000915751	0.060320955216770514
FILIPPI SYNDROME; FLPIS	0.000915751	0.060320955216770514
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.060320955216770514
RENPENNING SYNDROME 1; RENS1	0.000915751	0.060320955216770514
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000915751	0.060320955216770514
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000915751	0.060320955216770514
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.000915751	0.060320955216770514
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.060320955216770514
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000915751	0.060320955216770514
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000915751	0.060320955216770514
ATKIN-FLAITZ SYNDROME	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000915751	0.060320955216770514
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.060320955216770514
AL KAISSI SYNDROME; ALKAS	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000915751	0.060320955216770514
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000915751	0.060320955216770514
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000915751	0.060320955216770514
MEND SYNDROME; MEND	0.000915751	0.060320955216770514
AICARDI-GOUTIERES SYNDROME 7	0.000915751	0.060320955216770514
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000915751	0.060320955216770514
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000915751	0.060320955216770514
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.060320955216770514
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.060320955216770514
RAMON SYNDROME	0.000915751	0.060320955216770514
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.060320955216770514
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.060320955216770514
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000915751	0.060320955216770514
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000915751	0.060320955216770514
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.060320955216770514
DIAMINOPENTANURIA	0.000915751	0.060320955216770514
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.000915751	0.060320955216770514
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000915751	0.060320955216770514
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000915751	0.060320955216770514
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000915751	0.060320955216770514
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.060320955216770514
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.060320955216770514
LISSENCEPHALY 8; LIS8	0.000915751	0.060320955216770514
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000915751	0.060320955216770514
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.060320955216770514
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.060320955216770514
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.060320955216770514
CHROMOSOME 19p13.13 DELETION SYNDROME	0.000915751	0.060320955216770514
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000915751	0.060320955216770514
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.060320955216770514
MOWAT-WILSON SYNDROME; MOWS	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.060320955216770514
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.000915751	0.060320955216770514
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.060320955216770514
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000915751	0.060320955216770514
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000915751	0.060320955216770514
LISSENCEPHALY 1; LIS1	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.060320955216770514
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000915751	0.060320955216770514
KAPUR-TORIELLO SYNDROME	0.000915751	0.060320955216770514
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.060320955216770514
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.060320955216770514
JABERI-ELAHI SYNDROME; JABELS	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.060320955216770514
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.060320955216770514
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.060320955216770514
KLEEFSTRA SYNDROME 2; KLEFS2	0.000915751	0.060320955216770514
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000915751	0.060320955216770514
WAISMAN SYNDROME; WSMN	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000915751	0.060320955216770514
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000915751	0.060320955216770514
ZTTK SYNDROME; ZTTKS	0.000915751	0.060320955216770514
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.000915751	0.060320955216770514
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000915751	0.060320955216770514
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.060320955216770514
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000915751	0.060320955216770514
Myhre syndrome	0.000915751	0.060320955216770514
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.060320955216770514
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000915751	0.060320955216770514
SECKEL SYNDROME 1; SCKL1	0.000915751	0.060320955216770514
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000915751	0.060320955216770514
COFFIN-SIRIS SYNDROME 5	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.060320955216770514
NEURAMINIDASE DEFICIENCY	0.000915751	0.060320955216770514
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000915751	0.060320955216770514
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.060320955216770514
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000915751	0.060320955216770514
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000915751	0.060320955216770514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000915751	0.060320955216770514
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.060320955216770514
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.060320955216770514
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000915751	0.060320955216770514
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000915751	0.060320955216770514
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.000915751	0.060320955216770514
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000915751	0.060320955216770514
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000915751	0.060320955216770514
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000915751	0.060320955216770514
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.060320955216770514
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000915751	0.060320955216770514
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.060320955216770514
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.000915751	0.060320955216770514
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.060320955216770514
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.060320955216770514
KUFOR-RAKEB SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000915751	0.060320955216770514
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000915751	0.060320955216770514
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.000915751	0.060320955216770514
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.060320955216770514
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000915751	0.060320955216770514
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.000915751	0.060320955216770514
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.060320955216770514
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.060320955216770514
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.060320955216770514
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000915751	0.060320955216770514
POTOCKI-LUPSKI SYNDROME	0.000915751	0.060320955216770514
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000915751	0.060320955216770514
DIGEORGE SYNDROME; DGS	0.000915751	0.060320955216770514
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000915751	0.060320955216770514
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000915751	0.060320955216770514
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000915751	0.060320955216770514
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000915751	0.060320955216770514
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.060320955216770514
HYPER-BETA-ALANINEMIA	0.000915751	0.060320955216770514
FLYNN-AIRD SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.060320955216770514
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 90	0.000915751	0.060320955216770514
WEAVER SYNDROME	0.000915751	0.060320955216770514
CHROMOSOME 1p35 DELETION SYNDROME	0.000915751	0.060320955216770514
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.060320955216770514
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000915751	0.060320955216770514
KEUTEL SYNDROME; KTLS	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000915751	0.060320955216770514
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.060320955216770514
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.060320955216770514
DESANTO-SHINAWI SYNDROME	0.000915751	0.060320955216770514
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000915751	0.060320955216770514
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.060320955216770514
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.060320955216770514
HOLOPROSENCEPHALY 2; HPE2	0.000915751	0.060320955216770514
PELIZAEUS-MERZBACHER DISEASE	0.000915751	0.060320955216770514
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000915751	0.060320955216770514
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.060320955216770514
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000915751	0.060320955216770514
GAUCHER DISEASE, PERINATAL LETHAL	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000915751	0.060320955216770514
1p36 microdeletion syndrome	0.000915751	0.060320955216770514
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.060320955216770514
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.060320955216770514
SHUKLA-VERNON SYNDROME; SHUVER	0.000915751	0.060320955216770514
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000915751	0.060320955216770514
GRACILE BONE DYSPLASIA; GCLEB	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.060320955216770514
Adrenoleukodystrophy	0.000915751	0.060320955216770514
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000915751	0.060320955216770514
Angelman syndrome (Type 2)	0.000915751	0.060320955216770514
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000915751	0.060320955216770514
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.000915751	0.060320955216770514
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000915751	0.060320955216770514
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.060320955216770514
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.060320955216770514
TEMTAMY SYNDROME; TEMTYS	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000915751	0.060320955216770514
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.060320955216770514
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000915751	0.060320955216770514
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000915751	0.060320955216770514
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000915751	0.060320955216770514
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.060320955216770514
XQ25 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
GRISCELLI SYNDROME, TYPE 1	0.000915751	0.060320955216770514
THREONINEMIA	0.000915751	0.060320955216770514
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.060320955216770514
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.060320955216770514
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.060320955216770514
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.060320955216770514
NOONAN SYNDROME 7; NS7	0.000915751	0.060320955216770514
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
CLARK-BARAITSER SYNDROME	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000915751	0.060320955216770514
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000915751	0.060320955216770514
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000915751	0.060320955216770514
CODAS SYNDROME	0.000915751	0.060320955216770514
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.060320955216770514
KABUKI SYNDROME 1	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.060320955216770514
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.060320955216770514
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000915751	0.060320955216770514
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.060320955216770514
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.060320955216770514
ADAMS-OLIVER SYNDROME 1; AOS1	0.000915751	0.060320955216770514
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.060320955216770514
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.060320955216770514
EPILEPSY, READING	0.000915751	0.060320955216770514
#614483 PORENCEPHALY 2; POREN2	0.000915751	0.060320955216770514
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000915751	0.060320955216770514
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.060320955216770514
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000915751	0.060320955216770514
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000915751	0.060320955216770514
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000915751	0.060320955216770514
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.060320955216770514
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.060320955216770514
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000915751	0.060320955216770514
PETERS-PLUS SYNDROME; PTRPLS	0.000915751	0.060320955216770514
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.060320955216770514
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000915751	0.060320955216770514
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000915751	0.060320955216770514
HYPERLYSINEMIA, TYPE I	0.000915751	0.060320955216770514
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.060320955216770514
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.060320955216770514
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000915751	0.060320955216770514
CORNELIA DE LANGE SYNDROME 1	0.000915751	0.060320955216770514
WIEACKER-WOLFF SYNDROME	0.000915751	0.060320955216770514
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000915751	0.060320955216770514
Helsmoortel-van der Aa syndrome	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000915751	0.060320955216770514
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000915751	0.060320955216770514
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.060320955216770514
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.060320955216770514
POTOCKI-SHAFFER SYNDROME	0.000915751	0.060320955216770514
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 103	0.000915751	0.060320955216770514
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000915751	0.060320955216770514
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.060320955216770514
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000915751	0.060320955216770514
Fabry disease	0.000915751	0.060320955216770514
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.060320955216770514
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.060320955216770514
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000915751	0.060320955216770514
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.060320955216770514
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000915751	0.060320955216770514
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000915751	0.060320955216770514
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.060320955216770514
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.060320955216770514
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.060320955216770514
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.000915751	0.060320955216770514
PHENYLKETONURIA	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000915751	0.060320955216770514
PALLISTER-KILLIAN SYNDROME	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000915751	0.060320955216770514
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000915751	0.060320955216770514
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000915751	0.060320955216770514
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000915751	0.060320955216770514
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000915751	0.060320955216770514
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000915751	0.060320955216770514
Cerebral creatine deficiency syndrome 2	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000915751	0.060320955216770514
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000915751	0.060320955216770514
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.000915751	0.060320955216770514
ACROCALLOSAL SYNDROME; ACLS	0.000915751	0.060320955216770514
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000915751	0.060320955216770514
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000915751	0.060320955216770514
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
GAUCHER DISEASE, TYPE II	0.000915751	0.060320955216770514
611961 STEVENSON-CAREY SYNDROME	0.000915751	0.060320955216770514
MACDERMOT-WINTER SYNDROME	0.000915751	0.060320955216770514
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.060320955216770514
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.060320955216770514
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.060320955216770514
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000915751	0.060320955216770514
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000915751	0.060320955216770514
MENKES DISEASE	0.000915751	0.060320955216770514
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000915751	0.060320955216770514
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.060320955216770514
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.060320955216770514
FOUNTAIN SYNDROME	0.000915751	0.060320955216770514
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000915751	0.060320955216770514
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.060320955216770514
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000915751	0.060320955216770514
COFFIN-SIRIS SYNDROME 1; CSS1	0.000915751	0.060320955216770514
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000915751	0.060320955216770514
ANGELMAN SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000915751	0.060320955216770514
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000915751	0.060320955216770514
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.000915751	0.060320955216770514
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000915751	0.060320955216770514
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.060320955216770514
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.060320955216770514
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.060320955216770514
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.060320955216770514
FOLATE MALABSORPTION, HEREDITARY	0.000915751	0.060320955216770514
WITTEVEEN-KOLK SYNDROME	0.000915751	0.060320955216770514
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000915751	0.060320955216770514
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.060320955216770514
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.060320955216770514
COFFIN-SIRIS SYNDROME 2; CSS2	0.000915751	0.060320955216770514
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000915751	0.060320955216770514
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000915751	0.060320955216770514
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.000915751	0.060320955216770514
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000915751	0.060320955216770514
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.000915751	0.060320955216770514
GLASS SYNDROME	0.000915751	0.060320955216770514
C SYNDROME	0.000915751	0.060320955216770514
KIFAFA SEIZURE DISORDER	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.060320955216770514
HUNTINGTON DISEASE; HD	0.000915751	0.060320955216770514
Pontine tegmental cap dysplasia	0.000915751	0.060320955216770514
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000915751	0.060320955216770514
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000915751	0.060320955216770514
CROUZON SYNDROME	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000915751	0.060320955216770514
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.060320955216770514
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.000915751	0.060320955216770514
LANDAU-KLEFFNER SYNDROME	0.000915751	0.060320955216770514
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.060320955216770514
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000915751	0.060320955216770514
PRADER-WILLI SYNDROME; PWS	0.000915751	0.060320955216770514
Angelman syndrome (Type 1)	0.000915751	0.060320955216770514
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000915751	0.060320955216770514
ALZHEIMER DISEASE 3; AD	0.000915751	0.060320955216770514
Xq28 (MECP2) duplication	0.000915751	0.060320955216770514
COHEN SYNDROME	0.000915751	0.060320955216770514
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000915751	0.060320955216770514
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.060320955216770514
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000915751	0.060320955216770514
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000915751	0.060320955216770514
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.060320955216770514
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.060320955216770514
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000915751	0.060320955216770514
2q33.1 deletion syndrome	0.000915751	0.060320955216770514
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.060320955216770514
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.060320955216770514
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.060320955216770514
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.060320955216770514
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000915751	0.060320955216770514
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.000915751	0.060320955216770514
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.060320955216770514
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000915751	0.060320955216770514
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000915751	0.060320955216770514
INFANTILE SIALIC ACID STORAGE DISEASE	0.000915751	0.060320955216770514
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.060320955216770514
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000915751	0.060320955216770514
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.060320955216770514
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.060320955216770514
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.060320955216770514
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000915751	0.060320955216770514
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000915751	0.060320955216770514
COWDEN SYNDROME 5; CWS5	0.000915751	0.060320955216770514
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000915751	0.060320955216770514
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.060320955216770514
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000915751	0.060320955216770514
WEBB-DATTANI SYNDROME; WEDAS	0.000915751	0.060320955216770514
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000915751	0.060320955216770514
STURGE-WEBER SYNDROME	0.000915751	0.060320955216770514
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000915751	0.060320955216770514
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.060320955216770514
#602398 DESMOSTEROLOSIS	0.000915751	0.060320955216770514
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.060320955216770514
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.060320955216770514
ZIMMERMANN-LABAND SYNDROME 1	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000915751	0.060320955216770514
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.000915751	0.060320955216770514
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000915751	0.060320955216770514
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.060320955216770514
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
COWDEN SYNDROME 6; CWS6	0.000915751	0.060320955216770514
